The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of anlotinib combined chemotherapy as second-line and above therapy in HER2-negative advanced breast cancer.
 
Yuan Yuan
No Relationships to Disclose
 
Lili Zhang
No Relationships to Disclose
 
Ting Xu
No Relationships to Disclose
 
Weili Xiong
No Relationships to Disclose
 
Sainan Hu
No Relationships to Disclose
 
Jiayuan Huang
No Relationships to Disclose
 
Min Dong
No Relationships to Disclose
 
Xinyu Xu
No Relationships to Disclose
 
Kexin Lou
No Relationships to Disclose